PROTAGENIC THERAPEUTICS (PTIX) Total Assets by Year
PROTAGENIC THERAPEUTICS closed fiscal year 2026 with $3.7M in total assets, $1.0M in total liabilities and $2.6M in shareholder equity. The table below carries 12 fiscal years, from 2014 to 2026, and the quarters PROTAGENIC THERAPEUTICS has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PTIX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2610-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.7M | $2.0M-54.8% | $4.3M-46.2% | $8.0M-27.3% | $11.1M+1157.9% | $879K+4.4% | $842K+20.9% | $697K-60.9% | $1.8M-43.7% | $3.2M+28278.3% | $11K-58.5% | $27K |
| Total Liabilities | $1.0M | $5.3M+704.9% | $655K-41.5% | $1.1M+0.2% | $1.1M-44.9% | $2.0M+37.4% | $1.5M+62.7% | $908K+61.6% | $562K-18.0% | $685K+1.0% | $678K+357.6% | $148K |
| Total Equity | $2.6M | -$3.3M-190.5% | $3.7M-47.0% | $6.9M-30.4% | $9.9M+964.7% | -$1.1M-81.2% | -$634K-200.8% | -$211K-117.3% | $1.2M-50.8% | $2.5M+471.3% | -$667K-449.8% | -$121K |
PTIX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-K | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.8M-56.9% | $3.7M+3997.3% | $4.4M+126.5% | $5.0M+231.7% | $6.5M+342.3% | $89K-96.5% | $2.0M-54.8% | $1.5M-72.2% | $1.5M-78.8% | $2.6M-66.4% | $4.3M-46.2% | $5.4M-34.2% |
| Total Liabilities | $1.1M-89.7% | $1.0M-79.5% | $6.8M+29.4% | $9.7M+143.9% | $10.5M+224.9% | $5.0M+15.4% | $5.3M+704.9% | $4.0M+210.8% | $3.2M+113.9% | $4.4M+248.9% | $655K-41.5% | $1.3M+46.8% |
| Total Equity | $1.7M+143.4% | $2.6M+152.9% | -$2.4M+27.9% | -$4.7M-90.3% | -$4.0M-126.7% | -$5.0M-176.8% | -$3.3M-190.5% | -$2.5M-159.5% | -$1.8M-132.4% | -$1.8M-127.9% | $3.7M-47.0% | $4.2M-43.7% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More PROTAGENIC THERAPEUTICS financials
Frequently Asked Questions
What was PROTAGENIC THERAPEUTICS's total assets in fiscal year 2026?
PROTAGENIC THERAPEUTICS closed fiscal year 2026 with $3.7M in total assets, $1.0M in total liabilities and $2.6M in shareholder equity.
How has PROTAGENIC THERAPEUTICS's total assets changed over the years?
Across the 12 fiscal years this page covers, PROTAGENIC THERAPEUTICS (PTIX) total assets went from $27K in fiscal year 2014 to $3.7M in fiscal year 2026.
What was PROTAGENIC THERAPEUTICS's total assets in the most recent quarter?
PROTAGENIC THERAPEUTICS (PTIX) reported $2.8M in total assets in Q1 2027. This represents a decrease of 56.9% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what PROTAGENIC THERAPEUTICS (PTIX) reported on that line in every period on record.